Increased Efficiency of EtG/EtS with 2μm HALO® PCS C18

Bonded Phase: PCS C18
Market Segment: Clinical/Toxicology
Particle Size: 2 µm, 2.7 µm
Pore Size: 90 Å
Product Segment: SMALL MOLECULE
Separation Mode: Reversed Phase
USP Number: L1
Download File
Bonded Phase: PCS C18
Market Segment: Clinical/Toxicology
Particle Size: 2 µm, 2.7 µm
Pore Size: 90 Å
Product Segment: SMALL MOLECULE
Separation Mode: Reversed Phase
USP Number: L1
Download File